Leukemia Clinical Trials

Showing 5761-5780 of 10,987 trials

Bendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT04155840

This trial studies how well bendamustine and rituximab in combination with copanlisib work in treating patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. Drugs used in chemotherapy, such as bendamustine and rituximab, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Copanlisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving bendamustine and rituximab with copanlisib may work better than bendamustine and rituximab alone in treating chronic lymphocytic leukemia or small lymphocytic lymphoma.

Lymphoid LeukemiaNon-Hodgkin's LymphomaChronic Lymphocytic Leukemia+1 more

University of Washington1 participantsStarted Jan 2020

Seattle, Washington, United States

COMPLETED

Efficacy and Safety of PEMbrolizumab PD-L1-positive (>50% of Tumor Cells), Advanced NSCL Cancer(PEMBREIZH)

NCT05321212

This study was a French multicentric cross-sectional study retrospectively of 108 consecutive advanced NSCLC patients with a PD-L1 TPS ≥50% and without EGFR/ALK aberrations treated by pembrolizumab in first line.

Carcinoma, Non-Small-Cell LungImmunotherapy

University Hospital, Brest108 participantsStarted Jan 2019

Brest, France • Quimper, France

TERMINATED

Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy

NCT04858594

This is a prospective, observational study to establish the connection between periodontitis and BSI in AML patients planning to receive intensive chemotherapy.

Acute Myeloid Leukemia

Masonic Cancer Center, University of Minnesota3 participantsStarted May 2021

Minneapolis, Minnesota, United States

Bendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Efficacy and Safety of PEMbrolizumab PD-L1-positive (>50% of Tumor Cells), Advanced NSCL Cancer(PEMBREIZH)

Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy

Related Searches

A Study of LY3023414 in Participants With Advanced Cancer

Outcome of Specific IgE Level in Children With IgE-mediated Wheat Allergy After Stop Using Wheat Containing Skin Care

A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia

Subcutaneous Closed-Suction Drainage Affects Surgical Wounds Healing in Lower Gastrointestinal Open Surgery: a Randomized Controlled Study

Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies

BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC

Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies

Nivolumab After Cyclophosphamide and Doxorubicin Induction Therapy in NSCLC With PD-L1<10%

A Study of Tarceva vs. Avastin+Tarceva for Advanced NSCLC With EGFR m(+)

Evaluation of MRI Sequences for Ultra-rapid Acquisition of Bile Ducts Images

Osimertinib for Russian EGFR T790M Mutation-positive NSCLC Patients Who Progressed on or After EGFR TKI Therapy

Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children

Fear of Fall Related Factors in Chronic Stroke

Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy

Holter Monitoring of Critically-ill Childern in PICU at Sohag University Hospital

Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers

Fall Risk Assessment Using Hybrid Machine Learning and Deep Learning Approaches and a Novel Posturography